{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:53:02Z","timestamp":1790121182885,"version":"4.0.1"},"reference-count":52,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,10,1]]},"DOI":"10.5551\/jat.64639","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T22:30:43Z","timestamp":1712097043000},"page":"1370-1385","source":"Crossref","is-referenced-by-count":9,"title":["Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study"],"prefix":"10.5551","volume":"31","author":[{"given":"Eiko","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"},{"name":"Department of Medicine, Yokohama City University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ishiga","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"},{"name":"Department of Medicine, Yokohama City University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Kinguchi","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Kanaoka","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Saigusa","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yokohama City University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Mikami","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Yokohama City University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yabuki","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Yokohama City University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Goda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Yokohama City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Machida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Yokohama City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Physiology, Fukuoka University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Haruhara","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyasu","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Azushima","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Toya","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ: Peripheral Artery Disease: Past, Present, and Future. Am J Med, 2019; 132: 1133-1141","DOI":"10.1016\/j.amjmed.2019.04.043"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Raja A, Spertus J, Yeh RW, Secemsky EA: Assessing health-related quality of life among patients with peripheral artery disease: A review of the literature and focus on patient-reported outcome measures. Vasc Med, 2021; 26: 317-325","DOI":"10.1177\/1358863X20977016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Liles DR, Kallen MA, Petersen LA, Bush RL: Quality of life and peripheral arterial disease. J Surg Res, 2006; 136: 294-301","DOI":"10.1016\/j.jss.2006.06.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Agarwal S, Sud K, Shishehbor MH: Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011. J Am Coll Cardiol, 2016; 67: 1901-1913","DOI":"10.1016\/j.jacc.2016.02.040"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Makino H, Koezuka R, Tamanaha T, Ogura M, Matsuki K, Hosoda K, Harada-Shiba M: Familial hypercholesterolemia and lipoprotein apheresis. J Atheroscler Thromb, 2019; 26 : 679-687","DOI":"10.5551\/jat.RV17033"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Harada-Shiba M, Arai H, Ohmura H, Okazaki H, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, Yokote K: Guidelines for the diagnosis and treatment of adult familial hypercholesterolemia 2022. J Atheroscler Thromb, 2023; 30: 558-586","DOI":"10.5551\/jat.CR005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Agishi T, Kitano Y, Suzuki T, Miura A, Murakami J, Minagawa H, Ban K: Improvement of peripheral circulation by low density lipoprotein adsorption. ASAIO Trans, 1989; 35: 349-351","DOI":"10.1097\/00002480-198907000-00057"},{"key":"8","unstructured":"8) Tsuchida H, Shigematsu H, Ishimaru S, Iwai T, Akaba N, Umezu S: Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS). Int Angiol, 2006; 25: 287-292"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Weiss N, Julius U: Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results. Clin Res Cardiol Suppl, 2019; 14: 39-44","DOI":"10.1007\/s11789-019-00097-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Poller WC, Dreger H, Morgera S, Berger A, Flessenk\u00e4mper I, Enke-Melzer K: Lipoprotein apheresis in patients with peripheral artery disease and hyperlipoproteinemia(a). Atheroscler Suppl, 2015; 18 : 187-193","DOI":"10.1016\/j.atherosclerosissup.2015.02.032"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M-T, Corr\u00e0 U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, L\u00f8chen M-L, L\u00f6llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S, ESC Scientific Document Group: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2016; 37: 2315-2381","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gallego-Colon E, Daum A, Yosefy C: Statins and PCSK9 inhibitors: A new lipid-lowering therapy. Eur J Pharmacol, 2020; 878 : 173114","DOI":"10.1016\/j.ejphar.2020.173114"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Skeik N, Nowariak ME, Smith JE, Alexander JQ, Manunga JM, Mirza AK, Sullivan TM: Lipid-lowering therapies in peripheral artery disease: A review. Vasc Med, 2021; 26: 71-80","DOI":"10.1177\/1358863X20957091"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tsurumi-Ikeya Y, Tamura K, Azuma K, Mitsuhashi H, Wakui H, Nakazawa I, Sugano T, Mochida Y, Ebina T, Hirawa N, Toya Y, Uchino K, Umemura S: Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patients. Arterioscler Thromb Vasc Biol, 2010; 30: 1058-1065","DOI":"10.1161\/ATVBAHA.109.200212"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tamura K, Tsurumi-Ikeya Y, Wakui H, Maeda A, Ohsawa M, Azushima K, Kanaoka T, Uneda K, Haku S, Azuma K, Mitsuhashi H, Tamura N, Toya Y, Tokita Y, Kokuho T, Umemura S: Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease. Ther Apher Dial, 2013; 17: 185-192","DOI":"10.1111\/j.1744-9987.2012.01149.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ramunni A, Petrarulo F, Grasso C, Papagni S, Brescia P: Acute and chronic effects of therapeutic apheresis. Atheroscler Suppl, 2013; 14: 83-87","DOI":"10.1016\/j.atherosclerosissup.2012.10.018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Stefanutti C, Vivenzio A, Ferraro PM, Morozzi C, Belotherkovsky D: Apheresis-inducible cytokine pattern change in severe, genetic dyslipidemias. Cytokine, 2011; 56: 835-841","DOI":"10.1016\/j.cyto.2011.08.024"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) van Wijk DF, Sjouke B, Figueroa A, Emami H, van der Valk FM, MacNabb MH, Hemphill LC, Schulte DM, Koopman MG, Lobatto ME, Verberne HJ, Fayad ZA, Kastelein JJP, Mulder WJM, Hovingh GK, Tawakol A, Stroes ESG: Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia. J Am Coll Cardiol, 2014; 64: 1418-1426","DOI":"10.1016\/j.jacc.2014.01.088"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Drouin-Chartier J-P, Tremblay AJ, Bergeron J, Pelletier M, Laflamme N, Lamarche B, Couture P: Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia. J Clin Apher, 2016; 31: 359-367","DOI":"10.1002\/jca.21406"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Utsumi K, Kawabe M, Hirama A, Ueda K, Kamada Y, Arii K, Komaba Y, Katsura K-I, Iino Y, Katayama Y: Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis. Clin Chim Acta, 2007; 377: 198-200","DOI":"10.1016\/j.cca.2006.09.026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hara T, Kiyomoto H, Hitomi H, Moriwaki K, Ihara G, Kaifu K, Fujita Y, Higashiyama C, Nishiyama A, Kohno M: Low-density lipoprotein apheresis for haemodialysis patients with peripheral arterial disease reduces reactive oxygen species production via suppression of NADPH oxidase gene expression in leucocytes. Nephrol Dial Transplant, 2009; 24: 3818-3825","DOI":"10.1093\/ndt\/gfp342"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kopprasch S, Bornstein SR, Bergmann S, Graessler J, Julius U: Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques. Atheroscler Suppl, 2015; 18 : 80-84","DOI":"10.1016\/j.atherosclerosissup.2015.02.016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ueda E, Toya Y, Wakui H, Kawai Y, Azushima K, Fujita T, Saigusa Y, Yamanaka T, Yabuki Y, Mikami T, Goda M, Sugano T, Tamura K: Low-density-lipoprotein apheresis-mediated endothelial activation therapy to severe-peripheral artery disease study: Rationale and study design. Ther Apher Dial, 2020; 24: 524-529","DOI":"10.1111\/1744-9987.13546"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Morgan MB, Crayford T, Murrin B, Fraser SC: Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg, 2001; 33: 679-687","DOI":"10.1067\/mva.2001.112326"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Conijn AP, Jonkers W, Rouwet EV, Vahl AC, Reekers JA, Koelemay MJW: Introducing the Concept of the Minimally Important Difference to Determine a Clinically Relevant Change on Patient-Reported Outcome Measures in Patients with Intermittent Claudication. Cardiovasc Intervent Radiol, 2015; 38: 1112-1118","DOI":"10.1007\/s00270-015-1060-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Matsui Y, Furue M, Sanada H, Tachibana T, Nakayama T, Sugama J, Furuta K, Tachi M, Tokunaga K, Miyachi Y: Development of the DESIGN-R with an observational study: an absolute evaluation tool for monitoring pressure ulcer wound healing. Wound Repair Regen, 2011; 19: 309-315","DOI":"10.1111\/j.1524-475X.2011.00674.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nakagami H, Sugimoto K, Ishikawa T, Koshizaka M, Fujimoto T, Kiyohara E, Hayashi M, Nakagawa Y, Ando H, Terabe Y, Takami Y, Yamamoto K, Takeya Y, Takemoto M, Ebihara T, Nakamura A, Nishikawa M, Yao XJ, Hanaoka H, Yokote K, Rakugi H: Investigator-initiated clinical study of a functional peptide, SR-0379, for limb ulcers of patients with Werner syndrome as a pilot study. Geriatr Gerontol Int, 2019; 19: 1118-1123","DOI":"10.1111\/ggi.13782"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Frans FA, Nieuwkerk PT, Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJW: Statistical or clinical improvement? Determining the minimally important difference for the vascular quality of life questionnaire in patients with critical limb ischemia. Eur J Vasc Endovasc Surg, 2014; 47: 180-186","DOI":"10.1016\/j.ejvs.2013.10.012"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Stefanutti C, Julius U, Watts GF, Harada-Shiba M, Cossu M, Schettler VJ, De Silvestro G, Soran H, Van Lennep JR, Pisciotta L, Kl\u00f6r HU, Widhalm K, Moriarty PM, D\u2019Alessandri G, Bianciardi G, Bosco G, De Fusco G, Di Giacomo S, Morozzi C, Mesce D, Vitale M, Sovrano B, Drogari E, Ewald N, Gualdi G, Jaeger BR, Lanti A, Marson P, Martino F, Migliori G, Parasassi T, Pavan A, Perla FM, Brunelli R, Perrone G, Renga S, Ries W, Romano N, Romeo S, Pergolini M, Labbadia G, Di Iorio B, De Palo T, Abbate R, Marcucci R, Poli L, Ardissino G, Ottone P, Tison T, Favari E, Borgese L, Shafii M, Gozzer M, Pacella E, Torromeo C, Parassassi T, Berni A, Guardamagna O, Zenti MG, Guitarrini MR, Berretti D, Hohenstein B, Saheb S, Bjelakovic B, Williams H, De Luca N: Toward an international consensus\u2014Integrating lipoprotein apheresis and new lipid-lowering drugs. Journal of Clinical Lipidology, 2017; 11: 858-871.e3","DOI":"10.1016\/j.jacl.2017.04.114"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) The Emerging Risk Factors Collaboration: C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med, 2012; 367: 1310-1320","DOI":"10.1056\/NEJMoa1107477"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Iso H, Noda H, Ikeda A, Yamagishi K, Inoue M, Iwasaki M, Tsugane S: The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: The japan public health center-based study. J Atheroscler Thromb, 2012; 19: 756-766","DOI":"10.5551\/jat.11999"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Safarova MS, Ezhov MV, Afanasieva OI, Matchin YG, Atanesyan RV, Adamova IY, Utkina EA, Konovalov GA, Pokrovsky SN: Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Atheroscler Suppl, 2013; 14: 93-99","DOI":"10.1016\/j.atherosclerosissup.2012.10.015"},{"key":"34","unstructured":"34) Kitabatake A, Sato H, Hori M, Kamada T, Kubori S, Hoki N, Minamino T, Yamada M, Kato T: Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group. Clin Ther, 1994; 16: 416-428"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kajikawa M, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, Hidaka T, Kihara Y, Chayama K, Nakashima A, Goto C, Noma K, Higashi Y: Borderline ankle-brachial index value of 0.91-0.99 is associated with endothelial dysfunction. Circ J, 2014; 78: 1740-1745","DOI":"10.1253\/circj.CJ-14-0165"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Sato S, Masami K, Otsuki S, Tanaka S, Nakayama N, Makita S, Koshiyama H, Nohara R: Post-exercise ankle-brachial pressure index demonstrates altered endothelial function in the elderly. Jpn Clin Med, 2011; 2 : 21-24","DOI":"10.4137\/JCM.S7173"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pignatelli P, Menichelli D, Pastori D, Violi F: Oxidative stress and cardiovascular disease: new insights. Kardiol Pol, 2018; 76: 713-722","DOI":"10.5603\/KP.a2018.0071"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Signorelli SS, Marino E, Scuto S, Di Raimondo D: Pathophysiology of peripheral arterial disease (PAD): A review on oxidative disorders. Int J Mol Sci, 2020; 21: 4393","DOI":"10.3390\/ijms21124393"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Hussein H, Saheb S, Couturier M, Atassi M, Orsoni A, Carri\u00e9 A, Therond P, Chantepie S, Robillard P, Bruckert E, Chapman MJ, Kontush A: Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis. J Clin Lipidol, 2016; 10: 124-133","DOI":"10.1016\/j.jacl.2015.10.006"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE: Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J, 2003; 146: 168-174","DOI":"10.1016\/S0002-8703(03)00094-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Morimoto S, Yano Y, Maki K, Sawada K, Iwasaka T: Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment. Am J Nephrol, 2007; 27: 643-648","DOI":"10.1159\/000108634"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Dobbie LJ, Mackin ST, Hogarth K, Lonergan F, Kannenkeril D, Brooksbank K, Delles C: Validation of semi-automated flow-mediated dilation measurement in healthy volunteers. Blood Press Monit, 2020; 25: 216-223","DOI":"10.1097\/MBP.0000000000000448"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Craige SM, Kant S, Keaney JF Jr: Reactive oxygen species in endothelial function - from disease to adaptation -. Circ J, 2015; 79: 1145-1155","DOI":"10.1253\/circj.CJ-15-0464"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Incalza MA, D\u2019Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F: Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol, 2018; 100 : 1-19","DOI":"10.1016\/j.vph.2017.05.005"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Rossenbach J, Mueller GA, Lange K, Armstrong VW, Schmitto JD, Hintze E, Helfmann J, Konstantinides S, Koziolek MJ: Lipid-apheresis improves microcirculation of the upper limbs. J Clin Apher, 2011; 26: 167-173","DOI":"10.1002\/jca.20285"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Moriarty PM, Gibson CA, Kensey KR, Hogenauer W: Effect of low-density lipoprotein cholesterol apheresis on blood viscosity. Am J Cardiol, 2004; 93: 1044-1046","DOI":"10.1016\/j.amjcard.2003.12.059"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Bosch T, Wendler T, Jaeger BR, Samtleben W: Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients. Ther Apher, 2001; 5: 372-376","DOI":"10.1046\/j.1526-0968.2001.00368.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Kojima S, Ogi M, Yoshitomi Y, Kuramochi M, Ikeda J, Naganawa M, Hatakeyama H: Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis. Int J Artif Organs, 1997; 20: 178-183","DOI":"10.1177\/039139889702000310"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Kizaki Y, Ueki Y, Yoshida K, Yano M, Matsumoto K, Miyake S, Tominaga Y, Eguchi K, Yano K: Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease? Blood Coagul Fibrinolysis, 1999; 10: 341-349","DOI":"10.1097\/00001721-199909000-00004"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Iwagami M, Mochida Y, Ishioka K, Oka M, Moriya H, Ohtake T, Hidaka S, Kobayashi S: LDL-apheresis dramatically improves generalized calciphylaxis in a patient undergoing hemodialysis. Clin Nephrol, 2014; 81: 198-202","DOI":"10.5414\/CN107482"},{"key":"51","unstructured":"51) Yoshimura H, Noguchi S, Noguchi Y, Totani T, Fujiwara M, Hattori K, Shimazu K, Tanaka T: Effect of treatment prediction of LDL apheresis using the skin perfusion pressure. Japanese Journal of Apheresis, 2018; 37: 73-76"},{"key":"52","unstructured":"52) Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, Benetos A, Biffi A, Boavida J-M, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B, ESC National Cardiac Societies, ESC Scientific Document Group: 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J, 2021; 42: 3227-3337"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/10\/31_64639\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:35:46Z","timestamp":1728102946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/10\/31_64639\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64639","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"article-number":"64639"}}